Liquid biopsies timely and effective testing method for NSCLC patients in Canada

(International Association for the Study of Lung Cancer) Next-generation sequencing (NGS) of cell-free DNA (cfDNA) obtained from blood samples may improve diagnostic testing in patients with advanced NSCLC, and may also be faster and less expensive compared to standard tissue profiling, according to research presented today at the IASLC 2020 Lung Cancer Hot Topic: Liquid Biopsy Virtual Conference.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news